Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2017.73.9987
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Neutrophil Count Is Associated With Survival in Localized Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2010English

Validation of Surrogate End Points for Overall Survival in Advanced Colorectal Cancer: A Harmonized Approach Is Needed

Journal of Clinical Epidemiology
Epidemiology
2016English

Expression of KLF5 Is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

The Impact of Increasing Dose on Overall Survival in Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2015English

Therapeutic Effect of Apatinib on Overall Survival Is Mediated by Prolonged Progression-Free Survival in Advanced Gastric Cancer Patients

Oncotarget
Oncology
2016English

Circulating Inflammation Signature Predicts Overall Survival and Relapse-Free Survival in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Impact of Germline CHEK2 Mutations on Biochemical Relapse Free Survival and Metastasis Free Survival After Radical Treatment for Patients With Prostate Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Prm155 - Joint Modeling of Overall Survival and Progression Free Survival

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy